Public Companies
Cory Booker Sends MindMed (MNMD) Stock Up 10%
Source: Daniel Patrick Martin / Shutterstock.com
Mind Medicine (NASDAQ:MNMD) stock is heating up on Tuesday thanks to Tweets from Sen. Cory Booker (D-NJ).
In…
Mind Medicine (NASDAQ:MNMD) stock is heating up on Tuesday thanks to Tweets from Sen. Cory Booker (D-NJ).
In a video Tweet, the Senator discussed the regulations surrounding psychedelics. He notes that this keeps them from seeing therapeutic use, despite recent research that suggests there’s such a case for them.
During his Tweets, Booker references his and Sen. Rand Paul’s (R-KY)”Right to Try” bill. This is legislation that would allow incredibly ill patients to try certain restricted drugs, such as psilocybin and marijuana.
Here’s a portion of what Booker says in the video, as transcribed by Marijuana Moment.
“We see that some drugs, like certain psychedelics, can help vulnerable people deal with their addiction, their trauma, their anxiety, their depression and more. Let’s make these drugs available for research, study and—ultimately, hopefully—for constructive application.”
Why MNMD Stock is Rising
All of those discussions are incredibly important to MindMed. The company’s main focus is on using psychedelics as a form of treatment for certain patients. The idea of a bill easing access to these types of drugs has investors excited today.
With that excitement comes heavy trading of MNMD stock. As of this writing, more than 2.6 million shares of the stock have been traded. To put that in perspective, the company’s daily average trading volume is closer to 1.3 million shares.
MNMD stock is up 9.9% as of Tuesday morning.
There’s more of the latest stock market news worth diving into below!
We’ve got all of that news ready for investors without daily coverage of the market. Among that is why shares of Mullen Automotive (NASDAQ:MULN), MBLY, and BYD (OTCMKTS:BYDDY) stock are doing. You can get up to speed on all of this news at the following links!
More Tuesday Stock Market News
- Mullen Is Getting Ready to Resell 900 Million Shares of MULN Stock
- MBLY Stock IPO: When Does Mobileye Go Public? What Is the Mobileye IPO Price Range?
- BYD Company (BYDDY) Stock Rises as Quarterly Profits Quadruple
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
More From InvestorPlace
- Buy This $5 Stock BEFORE This Apple Project Goes Live
- The Best $1 Investment You Can Make Today
- Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
The post Cory Booker Sends MindMed (MNMD) Stock Up 10% appeared first on InvestorPlace.
psychedelics psilocybin mind medicine mindmed
-
Psychedelics1 week agoCybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Breakthrough Therapy Program for Major Depressive Disorder
-
Law & Regulation1 week agoGoing concern warnings cloud Xtacy Therapeutics’ shrunk losses
-
Psilocybin1 week agoAre Shrooms Legal in Oregon: Full Guide
-
Law & Regulation1 week agoNuminus reports declining revenue as the company restructures
-
Psychedelics1 week agoOptimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API)
-
Psychedelics1 week agoAtai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology
-
Psychedelics1 week agoPsyence Group’s NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial
-
Law & Regulation7 days agoClearmind signs agreement with Hebrew University for psychedelic compound rights